BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7896447)

  • 1. Receptor tyrosine kinases expressed in metastatic colon cancer.
    Craven RJ; Xu LH; Weiner TM; Fridell YW; Dent GA; Srivastava S; Varnum B; Liu ET; Cance WG
    Int J Cancer; 1995 Mar; 60(6):791-7. PubMed ID: 7896447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.
    Chen WS; Kung HJ; Yang WK; Lin Wc
    Int J Cancer; 1999 Nov; 83(5):579-84. PubMed ID: 10521789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
    Gutfeld O; Prus D; Ackerman Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
    J Histochem Cytochem; 2006 Jan; 54(1):63-73. PubMed ID: 16116035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.
    Balasubramani M; Day BW; Schoen RE; Getzenberg RH
    Cancer Res; 2006 Jan; 66(2):763-9. PubMed ID: 16424007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.
    Mao W; Irby R; Coppola D; Fu L; Wloch M; Turner J; Yu H; Garcia R; Jove R; Yeatman TJ
    Oncogene; 1997 Dec; 15(25):3083-90. PubMed ID: 9444956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
    Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
    Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.
    Okino T; Egami H; Ohmachi H; Takai E; Tamori Y; Nakagawa K; Nakano S; Akagi J; Sakamoto O; Suda T; Ogawa M
    Int J Oncol; 1999 Oct; 15(4):709-14. PubMed ID: 10493952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
    Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
    Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer.
    Tokunaga T; Oshika Y; Abe Y; Ozeki Y; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
    Br J Cancer; 1998 Mar; 77(6):998-1002. PubMed ID: 9528847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.
    Kuwai T; Nakamura T; Kim SJ; Sasaki T; Kitadai Y; Langley RR; Fan D; Hamilton SR; Fidler IJ
    Am J Pathol; 2008 Feb; 172(2):358-66. PubMed ID: 18202197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells.
    Cajot JF; Sordat I; Silvestre T; Sordat B
    Cancer Res; 1997 Jul; 57(13):2593-7. PubMed ID: 9205061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
    Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of differential gene expression patterns in human colon cancers.
    Hernandez A; Smith F; Wang Q; Wang X; Evers BM
    Ann Surg; 2000 Oct; 232(4):576-85. PubMed ID: 10998656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer.
    Wewer UM; Albrechtsen R
    Lab Invest; 1992 Aug; 67(2):253-62. PubMed ID: 1354271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines.
    Langerak AW; van der Linden-van Beurden CA; Versnel MA
    Biochim Biophys Acta; 1996 Feb; 1305(1-2):63-70. PubMed ID: 8605252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
    Dibb NJ; Dilworth SM; Mol CD
    Nat Rev Cancer; 2004 Sep; 4(9):718-27. PubMed ID: 15343278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
    Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
    Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
    Yu HG; Tong SL; Ding YM; Ding J; Fang XM; Zhang XF; Liu ZJ; Zhou YH; Liu QS; Luo HS; Yu JP
    Int J Cancer; 2006 Dec; 119(12):2724-32. PubMed ID: 16998832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.